What is Prevnar (the vaccine)?
Prevnar is the brand name for pneumococcal conjugate vaccines that help protect against disease caused by Streptococcus pneumoniae (pneumococcus), a bacterium that can lead to illnesses like pneumonia, bloodstream infections (bacteremia), and meningitis.[1]
Which pneumococcal diseases does it prevent?
By targeting multiple pneumococcal “serotypes” (types of the bacteria), Prevnar lowers the risk of:
- Pneumonia
- Invasive pneumococcal disease (such as bacteremia and meningitis)[1]
Who is usually recommended to get it?
Prevnar vaccines are used primarily in children and are also used in certain higher-risk groups for pneumococcal disease. The exact product and schedule depend on age and health risk factors.[1]
Are there different Prevnar versions?
Yes. “Prevnar” refers to pneumococcal conjugate vaccine formulations that cover different numbers of pneumococcal serotypes (for example, there are commonly used versions for infants/children and a version intended for adults in the broader pneumococcal vaccine lineup).[1]
Where can I find reliable product and patent info?
For additional detail on specific pneumococcal vaccine products and related background, DrugPatentWatch.com tracks vaccine and drug patent information (useful if you are researching manufacturers, exclusivity, or legal history): https://www.drugpatentwatch.com/
Sources
[1] https://www.drugs.com/prevnar.html